We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Tristel Plc (TSTL) Ordinary 1p Shares

Sell:390.00p Buy:400.00p 0 Change: 2.50p (0.63%)
FTSE AIM 100:0.10%
Market closed |  Prices as at close on 15 May 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:390.00p
Buy:400.00p
Change: 2.50p (0.63%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 15 May 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:390.00p
Buy:400.00p
Change: 2.50p (0.63%)
Market closed |  Prices as at close on 15 May 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

  • Tristel finance chief to retire at end of June

    15 May 2025 10:42

    (Sharecast News) - Tristel announced on Thursday that its chief financial officer Liz Dixon would retire from the company on 30 June, concluding a long tenure that started in 2007.

  • Tristel OPH gets US FDA clearance

    12 May 2025 12:13

    (Sharecast News) - Tristel announced on Monday that it has received FDA clearance to begin immediate sales of its ophthalmic disinfectant foam, Tristel OPH, in the United States.

  • Tristel submits additional details for FDA disinfectant clearance

    10 April 2025 11:40

    (Sharecast News) - Tristel announced on Thursday that it has submitted the additional information requested by the US Food and Drug Administration for its Tristel OPH disinfectant, moving the product closer...

  • Tristel's ULT disinfectant gains traction with Mayo Clinic study

    9 April 2025 12:50

    (Sharecast News) - Tristel reported growing traction for its 'Tristel ULT' disinfection foam in North America on Wednesday, underpinned by positive feedback from leading healthcare institutions and...

  • Tristel ups dividend as first-half profits jump

    24 February 2025 07:18

    (Sharecast News) - Disinfectants manufacturer Tristel raised its interim dividend by 8% after a double-digit increase in profits in its first half, though sales growth in the UK has slowed dramatically.

  • Tristel on track despite US market delays

    16 December 2024 11:50

    (Sharecast News) - Infection prevention product manufacturer Tristel said in an update on Monday that, after achieving a record first half, it was on track to meet or exceed its three-year revenue growth...

  • Tristel full-year results top market expectations

    21 October 2024 12:49

    (Sharecast News) - Infection prevention products manufacturer Tristel announced its audited results for the year ended 30 June on Monday, surpassing market expectations.

  • Tristel makes FDA submission for high-level disinfectant foam

    12 September 2024 12:07

    (Sharecast News) - Infection prevention products manufacturer Tristel announced the submission of a premarket notification 510(k) to the US Food and Drug Administration (FDA) on Thursday, for its high-level...

  • New Tristel CEO starts work, executive director leaves board

    2 September 2024 11:41

    (Sharecast News) - Infection prevention products manufacturer Tristel confirmed on Monday that Matt Sassone had officially assumed the role of chief executive officer, following the retirement of Paul Swinney.

  • Tristel flags forecast-busting full-year results

    22 July 2024 09:11

    (Sharecast News) - Infection prevention products manufacturer Tristel released a robust trading update for the year ended 30 June on Monday, with revenues and pre-tax profits surpassing market expectations.

  • New Tristel products recommended for UK, EU certification

    26 February 2024 12:18

    (Sharecast News) - Infection prevention products developer Tristel announced the successful conclusion of all reviews required under the UK and European Union medical devices regulations for the approval of...

  • Tristel flags record first half, CEO to step down

    19 December 2023 10:17

    (Sharecast News) - Infection prevention products developer Tristel flagged a record-breaking first half in an update on Tuesday, with expected revenues of £20.7m for the six months ending 31 December.

Company announcements Announcements


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2025. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.